A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

Alberto Carmona-Bayonas,David Gómez,Eva Martínez de Castro,Pedro Pérez Segura,José Muñoz Langa,Paula Jimenez-Fonseca,Manuel Sánchez Cánovas,Laura Ortega Moran,Ignacio García Escobar,Ana Belén Rupérez Blanco,Isaura Fernández Pérez, Purificación Martínez de Prado, Rut Porta I Balanyà,Teresa Quintanar Verduguez,Álvaro Rodríguez-Lescure,Andrés Muñoz

European Journal of Internal Medicine（2020）

引用 25|浏览22

暂无评分

摘要

•We present a snapshot of CAT in the era of immunotherapy and targeted therapies.•Thrombotic risk is dynamic related to specific oncological contexts.•The epidemiology and evolution of CAT is changing in recent years.•Clinicians should factor in the thrombotic potential of targeted therapies.

查看译文

关键词

Cancer,Heparin,Pulmonary embolism,Registry,Thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要